A. Marchini

发表

Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector

G. Barbanti-Brodano, R. Manservigi, P. Rimessi, 1990, Journal of virology.

The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential

E. Kieff, R. Longnecker, A. Marchini, 1992, Journal of virology.

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells

F. Wang, A. Marchini, E. Kieff, 1991 .

Epstein-Barr Virus(EBV)Recombinants: UseofPositive Selection Markers ToRescueMutants inEBV-Negative B-LymphomaCells

E. Kieff, Fred Wang, A. Marchini, 1991 .

Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation

R. Longnecker, A. Marchini, E. Kieff, 1993, Journal of virology.

Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle

T. Shenk, A. Marchini, Carl J. Baldick, 1997, Journal of virology.

TheOnlyDomainWhichDistinguishes Epstein-Barr Virus Latent MembraneProtein 2A(LMP2A)fromLMP2B Is Dispensable forLymphocyte Infection andGrowth Transformation InVitro; LMP2A IsTherefore Nonessential

R. Longnecker, A. Marchini, 1992 .

Inhibition of Antigen Presentation by the Glycine/Alanine Repeat Domain Is Not Conserved in Simian Homologues of Epstein-Barr Virus Nuclear Antigen 1

R. Johnson, A. Rickinson, N. Blake, 1999, Journal of Virology.

Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants

R. Longnecker, A. Marchini, E. Kieff, 1992, Journal of virology.

A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant

E. Kieff, J. Cohen, F. Wang, 1992, Journal of virology.

Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.

E. Kieff, F. Wang, A. Marchini, 1991, Journal of virology.

Cell Growth Transformation by Epstein Barr Virus

E. Kieff, C. Sample, R. Longnecker, 1991 .

Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo

R. Longnecker, A. Marchini, R. Herrold, 1996, Journal of virology.

Human Cytomegalovirus with IE-2 (UL122) Deleted Fails To Express Early Lytic Genes

A. Marchini, Haiqing Liu, Hua Zhu, 2001, Journal of Virology.

Herpes simplex virus expressing Epstein-Barr virus nuclear antigen 1.

E. Kieff, B. Roizman, M. Hummel, 1986, Virology.

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

E. Kieff, J. Cohen, J. Mannick, 1991, Journal of virology.

BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication

E. Kieff, J. Cohen, B. Tomkinson, 1991, Journal of virology.

Human monoclonal antibodies to influenza virus: IgG subclass and light chain distribution.

A. Frank, A. Marchini, H. Six, 1989, Viral immunology.

E7 protein of human papillomaviruses and its interaction with cellular pathways

M. Tommasino, A. Marchini, D. Kanduc, 1998 .

A Selectable MarkerAllowsInvestigation ofa Nontransforming Epstein-Barr VirusMutant

J. Cohen, Fred Wang, A. Marchini, 1992 .